CalciMedica (CALC) Earnings Date & Reports

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CALC is expected to report earnings to rise 35.29% to -46 cents per share on May 10

Q1'23

Est.

$-0.46

Q4'22

Beat

by $0.08

Q3'22

Missed

by $0.05

Q2'22

Beat

by $0.02

Q1'22

Missed

by $0.10

The last earnings report on March 20 showed earnings per share of -34 cents, beating the estimate of -41 cents. With 4.34K shares outstanding, the current market capitalization sits at 20.90M.

View a ticker or compare two or three

Compare

CALC